The Targeted Alpha Therapy Group is the result of collaborations among departments at the University of Gothenburg, Sahlgrenska University Hospital, and Chalmers University of Technology as well as different foreign centers such as the PET & Cyclotron Unit at Rigshospitalet in Copenhagen, the Memorial Sloan-Kettering Cancer Center in New York, and the Institute for Transuranium Elements in Karlsruhe, Germany.
The coordination of all research activities in the group is though perfomed by people working at different departments at the Sahlgrenska Academy, University of Gothenburg.
The main goal is to develop strategies for the treatment of disseminated cancer using alpha-particle emitters as the leading actor. The research areas covered by the Targeted Alpha Therapy Group include studies of the chemistry related to the labeling of radionuclides to different ligands, studies of pharmacokinetics and different aspects of radiation physics such as dosimetry, and clinical studies in which the developed treatment strategies are evaluated, such as in our recently published phase I study.
[24 Jan 2017]
[13 May 2016]
[2 May 2016]
[25 Mar 2016]
[14 Oct 2015]
[28 Sep 2015]
Department of Oncology
Jubileumskliniken, Blå stråket 2
Sahlgrenska University Hospital, 413 45 Göteborg, Sweden
46 (0)31 342 10 00